CANCER PHARMACOGENOMIC STUDIES IN LATIN AMERICA Page 161 In:
Pharmacogenomics in Latin America ISBN: 978-1-53611-031-9 Editor: Luis A. Quiñones© 2017 …

Cancer is a leading cause of death worldwide. The cancer incidence rate in Chile is
133.7/100,000 inhabitants and it is the second cause of death, after cardiovascular …

Pharmacogenetics is the study of genetically determined variations in the response to drugs
and toxic agents, and their implications on disease. Recently, the discipline has acquired …

Cancer is a leading cause of death worldwide. The cancer incidence rate in Chile is
133.7/100,000 inhabitants and it is the second cause of death, after cardiovascular …

e22050 Background: Pharmacogenomics has recently emerged as a major tool in the
clinical analysis of cancer treatment efficacy. Understanding how mutations alter drug …

The Human Genome Project has resulted in a new era in the field of pharmacogenetics in
which researchers are rapidly discovering new genetic variation, which may help to explain …

e13607 Background: Pharmacogenetic is the study of genetic modifications influence on
drugs action. Recent studies have suggested that some genetic polymorphisms may have …

e15082 Background: Adverse drug reactions are an important cause of morbidity and
mortality commonly found in different therapeutic regimens, particularly in oncologic. About …

Over the past decades, several studies have shown that tumor-related somatic and germline
alterations predicts tumor prognosis, drug response and toxicity. Latin American populations …

During the past decade, human genetic research has made considerable progress, with
advances in both genome analysis techniques and international research infrastructure for …